Reading a newborn’s entire genome can speed diagnosis of rare disease. Rapid sequencing now returns results in days for critically ill infants. It is moving from research into intensive care.
Genome in days
Speed transformed it. Rapid pipelines return results fast. Time is critical for sick infants.
Rare disease
The target is clear. Many infant illnesses are genetic. Sequencing finds the cause.
Faster diagnosis
Care improves. A quick answer guides treatment. Odysseys shorten.
Cost falling
Access grows. Sequencing keeps getting cheaper. Routine use nears.
Ethical care
Sensitivity matters. Incidental findings raise questions. Counseling is needed.
Screening debate
Scope is discussed. Whether to sequence all newborns is contested. Policy evolves.
The bottom line
Rapid whole-genome sequencing now diagnoses rare disease in critically ill newborns within days. Falling costs push it toward routine use. Ethics and the scope of newborn screening remain debated.
